Bioavailability Over Time

Bioavailability Over Time is a pharmacokinetic metric that quantifies the rate and extent to which a drug or substance becomes available at the site of action as a function of time following administration.

8

Publications

358

Citations

26

Authors

13

Institutions

Publications per year

2017–2026

1

Authors

26

  1. GE
    Grigori Enikolopov

    Cold Spring Harbor Laboratory, United States

    1 publications · 18 citations

    1

    h-index

  2. WL
    W Lang

    Teikoku Pharma (United States), United States

    1 publications · 63 citations

    1

    h-index

  3. DH
    D. Hötzel

    Paderborn University, Germany

    1 publications · 35 citations

    1

    h-index

  4. HC
    Hyman Chai

    University of Colorado Denver, United States

    1 publications · 12 citations

    1

    h-index

  5. VV
    Vsevolod V. Belousov

    Institute of Bioorganic Chemistry, Russia

    1 publications · 18 citations

    1

    h-index

1–5 of 26

Venues

  1. PubMed

    Repository · 2 publications · 47 citations

    2

    h-index

  2. The Medical Journal of Australia

    MJA · 1 publications · 63 citations

    1

    h-index

  3. Histochemistry and Cell Biology

    1 publications · 18 citations

    1

    h-index

  4. European Journal of Clinical Pharmacology

    1 publications · 131 citations

    1

    h-index

  5. Maturitas

    1 publications · 41 citations

    1

    h-index

1–5